Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Lacking Emotional Support May Impact Quality of Life in Older Patients With GI Cancers
July 1st 2023Patients 60 years and older with gastrointestinal cancers who reported inadequate emotional support were more likely to have poorer physical and mental quality of life, although no effect was observed in overall survival.
FDA Grants Capivasertib Plus Faslodex Priority Review for Breast Cancer
June 13th 2023The application for capivasertib plus Faslodex in patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer has also been granted priority review, meaning that the FDA has six months to make a decision.
Pausing Endocrine Therapy for Pregnancy May Not Impact Breast Cancer Recurrence Risk
May 30th 2023Women with hormone receptor-positive breast cancer who temporarily interrupted endocrine therapy for pregnancy had a similar recurrence rate to those from a control group, but one expert said that stopping therapy for a short time is still an important decision.
Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients
May 25th 2023Patients born outside of the U.S. may have improved liver cancer survival rates compared with U.S.-born patients, although more research is needed to determine what may be driving this effect, research showed.